Phase II Trial of Tipifarnib as Maintenance Therapy in First Complete Remission in Adults with Acute Myelogenous Leukemia and Poor-Risk Features
2008 ◽
Vol 14
(10)
◽
pp. 3077-3082
◽
2003 ◽
Vol 9
(2)
◽
pp. 108
2008 ◽
Vol 14
(2)
◽
pp. 187-196
◽
2011 ◽
Vol 17
(3)
◽
pp. 401-411
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. 7081-7081